Trials / Not Yet Recruiting
Not Yet RecruitingNCT06059313
Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders
Relationship Between Premorbid Personality Traits and Cognitive and Behavioral Disorders
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Damages in frontal area present in neurodegenerative disease (frontotemporal degeneration, frontal variant of Alzheimer disease) and in psychiatric disease (bipolar disorder) can affect behavior and cognition including social cognition. Symptoms vary both quantitatively and qualitatively from disease to another and from person to person. It cannot be completely excluded that in some cases, factors of susceptibility such as premorbid personality traits lead to frontal fragility. The study will assess the relationship between premorbid profile using NEO-PI 3 inventory and cognitive and behavioral/psychobehavioral manifestations in patients with behavioral variant of frontotemporal disorder (bvFTD), phenocopy frontotemporal dementia (phFTD), frontal variant of Alzheimer disease, bipolar disorder characterized with frontal damages.
Conditions
- Behavioral Variant of Frontotemporal Disorder (bvFTD)
- Phenocopy Frontotemporal Dementia (phFTD)
- Frontal Variant of Alzheimer Disease
- Bipolar Disorder
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Submission of the NEO-PI-3 questionnaire | The questionnaire contains 240 statements. For each statement, the patient chooses the answer that best corresponds to their choice (FD: strongly disagree - D: disagree - N: neutral - A: agree - FA: strongly agree). |
| OTHER | Submission of the Interpersonal Reactivity Index questionnaire (IRI) | The test assesses two cognitive and two affective components of empathy that influence each other and affect attitudes and behaviors toward others. |
Timeline
- Start date
- 2023-10-01
- Primary completion
- 2026-10-01
- Completion
- 2027-02-01
- First posted
- 2023-09-28
- Last updated
- 2023-10-03
Source: ClinicalTrials.gov record NCT06059313. Inclusion in this directory is not an endorsement.